Case report reveals successful catheter ablation for ventricular arrhythmias in arrhythmogenic mitral valve prolapse, indicating the need for ICD therapy.
Key Points
Catheter ablation eliminated the arrhythmic focus, allowing the patient to remain arrhythmia-free for over two years.
Critical markers like bileaflet prolapse and late gadolinium enhancement were identified through advanced imaging techniques.
Electrophysiological study confirmed ventricular fibrillation triggered by papillary muscle PVCs as the underlying arrhythmia mechanism.
Expert consensus recommends implantable cardioverter-defibrillator therapy for high-risk patients, regardless of ablation outcomes.